Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)

This study has been completed.
ReSearch Pharmaceutical Services, Inc.
Information provided by (Responsible Party):
UCB Pharma ( UCB Pharma SA ) Identifier:
First received: February 1, 2012
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)